Effectiveness of Attentional Bias Modification Combined With Cognitive Behavioral Therapy in Reducing Relapse Risk and Cravings in Male Patients With Alcohol Use Disorder: A Quasi-Randomized Controlled Trial

Effectiveness of Combined Therapy for Alcohol Use Disorder

Study Overview

This study explores how combining Attention Bias Modification (ABM) with Cognitive Behavioral Therapy (CBT) can help reduce relapse risk and cravings in men with Alcohol Use Disorder (AUD).

Background

AUD involves strong dependence on alcohol and difficulty controlling impulses. ABM helps individuals focus less on alcohol-related triggers. This research aims to see if ABM, when paired with CBT, can further decrease cravings and relapse chances.

Study Method

In this trial, male patients with AUD were split into two groups:

Intervention Group: Received ABM along with CBT.
Control Group: Received only CBT with a placebo.

Over six weeks, participants attended weekly sessions. Their relapse risk and cravings were measured using specific scales.

Results

Both groups showed a decrease in relapse risk and cravings, but there was no significant difference between the two groups. This indicates that while the combined therapy did not outperform CBT alone, CBT itself is effective in treating AUD.

Conclusions

Even though the combination of ABM and CBT didn’t show a significant advantage, the reduction in both groups suggests that CBT is beneficial for AUD treatment. Future research should focus on more personalized approaches in real-world settings.

Clinical Implications

Clinical trials are essential for developing effective treatments. Our platform, DocSym, integrates ICD-11 standards and clinical protocols to support healthcare providers.

Streamlining Healthcare

In today’s healthcare landscape, efficiency is key. Our mobile apps facilitate scheduling, treatment monitoring, and telemedicine, enhancing patient care and expanding digital services.